Capsular types and antimicrobial resistance ofStreptococcus pneumoniae isolated in Korea

  • Y. Chong
  • K. Lee
  • O. H. Kwon
  • J. Henrichsen


The capsular types and the MICs of penicillin G and other antimicrobial agents were determined for 89 isolates ofStreptococcus pneumoniae. MICs of penicillin G ranged from 0.015 to 2 mg/l, with 29 % and 48 % of the isolates exhibiting intermediate resistance and complete resistance, respectively. All isolates were susceptible to teicoplanin and vancomycin, but 81 % and 43 % of the penicillin G-resistant strains were intermediately resistant to cefotaxime and imipenem, respectively. Strains belonged to 16 different capsular types: 73 % belonged to types 19F and 23F, and 97 % of strains belonging to these two types exhibited either intermediate or complete resistance to penicillin G.


Internal Medicine Penicillin Vancomycin Antimicrobial Agent Cefotaxime 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Watson DA, Musher DM, Jacobson JW, Verhoef J: A brief history of the pneumococcus in biomedical research: a panoply of scientific discovery. Clinical Infectious Diseases 1993, 17: 913–924.PubMedGoogle Scholar
  2. 2.
    Klugman KP: Pneumococcal resistance to antibiotics. Clinical Microbiology Reviews 1990, 3: 171–196.PubMedGoogle Scholar
  3. 3.
    National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS, Villanova, PA, 1993.Google Scholar
  4. 4.
    Jorgensen JH, Swenson JM, Tenover FC, Ferraro MJ, Hindler JA, Murray PR: Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing ofStreptococcus pneumoniae. Journal of Clinical Microbiology 1994, 32: 2448–2459.PubMedGoogle Scholar
  5. 5.
    Otin CL, Morros TJ, Sala IS: Antibiotic susceptibility ofStreptococcus pneumoniae from pediatric patients. Journal of Antimicrobial Chemotherapy 1988, 22: 659–665.PubMedGoogle Scholar
  6. 6.
    Linares J, Pallarés R, Alonso T, Perez JL, Ayats J, Gudiol F, Viladrich PF, Martin R: Trends in antimicrobial resistance of clinical isolates ofStreptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979–1990). Clinical Infectious Diseases 1992, 15: 99–105.PubMedGoogle Scholar
  7. 7.
    Gray MB, Dillon HC Jr: Clinical and epidemiologic studies of pneumococcal infection in children. Pediatric Infectious Diseases 1986, 5: 201–207.Google Scholar
  8. 8.
    Haglund LA, Istre GR, Pickett DA, Welch DF, Fine DP, the Pneumococcus Study Group: Invasive pneumococcal disease in central Oklahoma: emergence of high-level penicillin resistance and multiple antibiotic resistance. Journal of Infectious Diseases 1993, 168: 1532–1540.PubMedGoogle Scholar
  9. 9.
    Soares S, Kristinsson KG, Musser JM, Tomasz A: Evidence for the introduction of a multiresistant clone of serotype 6BStreptococcus pneumoniae from Spain to Iceland in the late 1980s. Journal of Infectious Diseases 1993, 168: 158–163.PubMedGoogle Scholar
  10. 10.
    Munoz R, Coffey TJ, Daniels M, Dowson CG, Laible G, Sasal J, Hakenbeck R, Jacobs M, Musser JM, Spratt BG, Tomasz A: Intercontinental spread of a multiresistant clone of serotype 23FStreptococcus pneumoniae. Journal of Infectious Diseases 1991, 164: 302–306.PubMedGoogle Scholar
  11. 11.
    Goldstein FW, Geslin P, Acar JF, the French Study Group: Comparative activity of teicoplanin and vancomycin against 400 penicillin susceptible and resistantStreptococcus pneumoniae. European Journal of Clinical Microbiology & Infectious Diseases 1994, 13: 33–34.Google Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgese Hschaft mbH 1995

Authors and Affiliations

  • Y. Chong
    • 1
  • K. Lee
    • 1
  • O. H. Kwon
    • 1
  • J. Henrichsen
    • 2
  1. 1.Department of Clinical PathologyYonsei University College of MedicineSeoulKorea
  2. 2.Statens SeruminstitutCopenhagen SDenmark

Personalised recommendations